相关实验视频

Updated: Jul 5, 2026

Vessel-sparing Excision and Primary Anastomosis

Vessel-sparing Excision and Primary Anastomosis

Published on: January 7, 2019

在可调节的转闭器男性系统植入后的中长期结果

Samra Jasarevic¹, Doroteja Jankovic¹, Georg C Hutterer¹

¹Department of Urology, Medical University of Graz, Graz, Austria.

|December 3, 2024

概括

可调节的TransObturator男性系统 (ATOMS) 显著减少了用于男性压力尿失禁 (SUI) 的使用量. 然而,大约三分之一的患者需要装置扩展,特别是那些有复发性或严重的SUI患者.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
手术创新在外科创新.
男人自制管理管理

背景情况:

男性的压力尿失禁 (SUI) 显著影响生活质量.
可调节的转换器男性系统 (ATOMS) 是用于SUI治疗的设备.
评估ATOMS结果对于患者的选择和管理至关重要.

研究的目的:

评估ATOMS设备在治疗男性SUI中的有效性和安全性.
为了确定ATOMS植入后的抑郁率和并发症概况.
为了确定与ATOMS探索相关的风险因素.

主要方法:

在2010年至2021年间接受了ATOMS植入的80名患者的回顾性分析.
主要终点包括失禁状态和并发症率.
使用卡普兰-梅尔和考克斯回归模型分析了植入物存活率和扩张风险因素.

主要成果:

植入后观察到每天使用子的显著减少 (每天4到2个子).
一年和五年植入物存活率分别为0.89和0.71.
在27.5%的患者中发生了膨胀,对于那些先前进行了失禁手术,高格里森得分 (ISUP ≥4) 和大量使用手术前子 (>250g/天) 的人来说,风险更高.

结论:

原子植入物有效地减少了男性的子需求.
在中期随访中存在显著的扩散率 (根据卡普兰-梅尔估计约为35%).
患有复发性或严重SUI的患者应接受关于扩张风险增加的咨询.

更多相关视频

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy

Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy

Published on: June 16, 2022

相关概念视频

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

Intrauterine Drug Delivery Systems

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...